Latest news on Laboratorytalk categorised by supplier
Roche Nimblegen
Address:
1 Science Ct
Madison
53711
USA
Telephone: (USA) +1 608 218 7609
http://www.nimblegen.com
Our RSS feed for news from Roche Nimblegen
Request to receive our free email newsletter each week
Listing of all 11 news releases from Roche Nimblegen:
Sequence capture for targeted genome resequencing
Roche NimbleGen has announced the commercial launch of its NimbleGen Sequence Capture technology for scientists interested in selecting targeted regions of the genome for high-throughput sequencing
News from Roche Nimblegen ( 8 April 2008)
NimbleGen and Affymetrix expand license agreement
Roche NimbleGen, a company of Roche Applied Science, and Affymetrix have expanded the terms of the license to a number of Affymetrix patents originally granted in October 2006
News from Roche Nimblegen (17 March 2008)
Array pinpoints genomic aberrations
User application article Researchers at the University of Washington and the Howard Hughes Medical Institute have discovered several new genetic causes of mental retardation, according to a study published in Nature Genetics
News from Roche Nimblegen (15 August 2006)
David Snyder appointed CFO of NimbleGen Systems
NimbleGen Systems, a supplier of flexible, high-density DNA microarrays used in the fastest growing markets for genome research, has named David S Snyder as chief financial officer
News from Roche Nimblegen ( 9 August 2006)
Limited Access program for NimbleChip hd2
A number of limited access partners have been selected to work with the company's second-generation NimbleChip HD2 microarrays, each containing more than 2 million probes.
News from Roche Nimblegen (26 July 2006)
Jivan and Nimblegen partner in splice array market
Splice variant microarrays have the potential to replace gene expression arrays for clinical markers, diagnostics, and target validation research due to greater specificity and biological relevance
News from Roche Nimblegen ( 6 February 2006)
NIAID researchers show how promising TB drug works
Technical background article Scientists from the National Institute of Allergy and Infectious Diseases (NIAID) have determined how a promising drug candidate attacks the bacterium that causes tuberculosis (TB)
News from Roche Nimblegen ( 5 January 2006)
Prevalence of genomic deletions between humans
User application article Researchers at the University of Chicago and the Wellcome Trust Sanger Institute have determined that small deletions in the human genome occur in a much greater number than previously assumed
News from Roche Nimblegen (16 December 2005)
Another $8.2 million finance raised
Provider of flexible high-density microarray products and services for a number of emerging applications in genetic analysis, has raised a total of $50 million since its inception in 1999
News from Roche Nimblegen ( 6 December 2005)
Another $12.5 million in financing
NimbleGen Systems has announced the closing of its series D financing in the amount of $12.5 million; it has now raised $32.5 million altogether
News from Roche Nimblegen (24 April 2003)
Expanding reach to Japan and Asia
Appointment of exclusive distributor in Japan is part of strategy to serve functional genomics research throughout the Asia-Pacific region
News from Roche Nimblegen (21 April 2003)
